Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 4Unknown 2Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Colorectal Neoplasms 5Melanoma 4Carcinoma, Renal Cell 4Carcinoma, Transitional Cell 3Uterine Cervical Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mesothelioma 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Advanced Solid Tumor 2Adenocarcinoma Of Esophagus 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Locally Advanced Rectal Cancer 1

Interventions

Cisplatin 11Gemcitabine 10Radiotherapy, Intensity-Modulated 6Capecitabine 6Drug Therapy 3Docetaxel 3toripalimab 2spartalizumab 2pembrolizumab 2nimotuzumab 2fludarabine 2atezolizumab 2Specimen Handling 2Platinum 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fluorouracil 2Disulfides 2Cyclophosphamide 2Carboplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2tislelizumab 1sintilimab 1penpulimab 1olaparib 1fludarabine phosphate 1dehydroftorafur 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Nasopharyngeal Carcinoma × tislelizumab × Clear all
NCT05211232 2026-05-29

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Active not recruiting
450 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡